Why clinical context comes first
Changes in sensation, strength, balance, memory or concentration can have many causes. HLC care begins by clarifying symptoms and the appropriate clinical assessment. A large antibody panel is not a substitute for a neurological examination or standard diagnostic pathways.
What the panel can include
The source groups antibody findings around neural structures and pathways, including myelin-related, neuromuscular and other targets. These are laboratory antibody measurements, not images of nerve damage or direct measurements of brain function. Their clinical relevance differs between targets.
Any included infection-related antibodies need their own interpretation; an antibody pattern alone does not establish a current infection. An optional genetic component, if ordered, is a separate DNA test and should not be confused with the antibody profile.
Understanding uncertainty
A flagged result is not proof that an antibody is causing symptoms. False-positive or clinically irrelevant findings are possible, particularly when testing people without a matching clinical picture. A negative panel cannot exclude every neurological or autoimmune disorder.
What happens after a finding
Before ordering, agree who will interpret the results and how a consequential finding will be confirmed. The next step may be a targeted standard assay or specialist referral. The panel alone is not a basis for immunotherapy, antimicrobial treatment or predictions about dementia.